Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Voyager Therapeutics, Inc. - Common Stock (NQ:VYGR)

3.430 +0.150 (+4.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Voyager Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
7 Top-Rated Biotech Stocks to Buy for Q4
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter. 
Via InvestorPlace
Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024
Via Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Voyager Therapeutics' TRACER Capsids Show Encouraging Action In Animal Models
Via Benzinga
Everything You Need To Know To Get Started With Crypto
By Voyager's Charlotte Siller, provided exclusivel... 
Via Benzinga
95 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II... 
Via Benzinga
The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
83 Biggest Movers From Yesterday
Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
57 Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Voyager Therapeutics Earnings Perspective: Return On Capital Employed
According to Benzinga Pro, during Q4, Voyager Therapeutics (NASDAQ:VYGR) earned $5.71 million, a 122.71% increase from the preceding quarter. Voyager Therapeutics also posted a... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results. Kala... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Kala Pharmaceuticals (NASDAQ:KALA) stock rose 86.8% to $1.14 during Tuesday's regular session. The current volume of 2.6 million shares is 326.2% of Kala... 
Via Benzinga
60 Stocks Moving In Tuesday's Mid-Day Session
Gainers Enservco Corporation (NYSE: ENSV) surged 228% to $8.20 after jumping around 85% on Monday. Hycroft Mining Holding Corporation (NASDAQ: HYMC) rose 168% to $0.8850. Hycroft... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Stealth BioTherapeutics (NASDAQ:MITO) shares increased by 22.1% to $0.65 during Tuesday's pre-market session. The company's market cap stands at $37.4... 
Via Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... 
Via Benzinga
Recap: Voyager Therapeutics Q4 Earnings
Voyager Therapeutics (NASDAQ:VYGR) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:15 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Voyager Therapeutics Shares Jump On Novartis Option Agreement For Gene Therapy Programs
Novartis AG (NYSE: NVS) has entered a license option agreement with Voyager Therapeutics Inc (NASDAQ: VYGR) for three capsids to use in potential gene... 
Via Benzinga
30 Stocks Moving in Tuesday's Pre-Market Session
Gainers Nine Energy Service, Inc. (NYSE: NINE) rose 63% to $5.86 in pre-market trading after the company reported upbeat Q4 results. The company’s stock jumped over... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Avinger (NASDAQ:AVGR) stock moved... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) stock... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock rose 31.09% to $6.45 during Monday's pre-market session. The company's market cap stands at $44.9 million. Provention Bio (... 
Via Benzinga
Voyager Therapeutics's Cancer Antibody Program Shows Encouraging Preclinical Action
Voyager Therapeutics Inc (NASDAQ: VYGR) announced preclinical data from a new vectorized anti-HER2 antibody program. Data showed that IV dosing of a proprietary... 
Via Benzinga
How Good Are Voyager Therapeutics's Earnings? | Return On Capital Employed
According to Benzinga Pro data, during Q3, Voyager Therapeutics (NASDAQ:VYGR) posted sales of $1.50 million. Earnings were up 12.03%, but Voyager Therapeutics still reported an... 
Via Benzinga
The Jobs Report and Other Stock Market News
What's been going on? 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Sio Gene Therapies (NASDAQ:SIOX) stock moved upwards by 22.79% to $2.64 during Thursday's regular session. The current volume of 17.1 million shares is 2411.03... 
Via Benzinga
Top 10 DeFi Projects To Watch In 2022
By Voyager's Charlotte Siller, provided exclusive... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.